Skip to main content
. Author manuscript; available in PMC: 2009 Jan 30.
Published in final edited form as: Vaccine. 2007 Dec 4;26(5):664–676. doi: 10.1016/j.vaccine.2007.11.045

Figure 2.

Figure 2

Tissue distribution of virus after intra-nasal infection. Groups of three C57BL/6 mice were infected intra-nasally with 106 pfu of wtVACV and the indicated mutant VACV constructs. Tissues were harvested at 4 days post-infection, processed and titrated in RK-13 cell line. The figure represents the average titer per gram of tissue of the three mice infected with each virus.